-
Mashup Score: 0Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard | Milken Institute - 5 month(s) ago
With the end of the COVID-19 public health emergency in May 2023, we looked back at previous recommendations and developed a post-pandemic scorecard to keep these issues front and center with the biomedical innovation ecosystem.
Source: milkeninstitute.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 7
The Future of Data-Driven Personalized Medicine: Keynote Reflections From Amy Abernethy, Chief Medical Officer and President at Verily.
Categories: General Medicine News, Hem/OncsTweet-
I'm en route to the #PersonalizedMedicine Conference where tomorrow I'll give a keynote, "Unlocking the Future of Precision Health Through Participant-Centric Evidence Generation". Looking forward to it! https://t.co/zJp7te4qV6
-
-
Mashup Score: 2Georgiamune and Verily announce strategic partnership to advance novel cancer treatment | Verily | Alphabet Precision Health Company - 6 month(s) ago
Gaithersburg, MD and South San Francisco, CA – Oct.
Source: verily.comCategories: General Medicine News, Hem/OncsTweet-
Yesterday we announced an exciting new partnership with Georgiamune Inc. to advance cancer treatment. This collaboration will combine our expertise in clinical research with Georgiamune’s innovative approach to immunotherapy development. https://t.co/CD3tCKpoJQ https://t.co/j8LC3TZ4LA
-
-
Mashup Score: 0Cell/Gene Therapy Is Ripe For Real-World Data Given Length Of Follow-Up Required, Abernethy Says - 7 month(s) ago
The former principal deputy commissioner outlined what she sees as the future data requirements for real world evidence and why cell and gene therapy will lead the way.
Source: pink.citeline.comCategories: Latest Headlines, Oncologists1Tweet-
Cell and gene therapies will require new evidence generation approaches to meet regulatory requirements for long term follow-up. This @PharmaPinkSheet article by @Kate_Rawson covers my remarks at @CancerResrch’s meeting on how we can build what’s needed. https://t.co/veH1hA5qdt
-
-
Mashup Score: 0How health care leaders are navigating the industry’s top challenges—and opportunities - Health Evolution - 8 month(s) ago
At Health Evolution’s 2023 Summit, CEOs from health systems, health plans, and life sciences companies, as well as select policymakers, investors, retailers, and technology leaders, came together to discuss the top challenges and opportunities facing the health care industry—and to chart a path forward together. Read highlights from those conversations, featuring perspectives from Meera Mani, MD, PhD, Partner, Town Hall Ventures; Hemant Taneja, CEO & Managing Director, General Catalyst; Frederick Isasi, Executive Director, Families USA; Alice Chen, MD, Chief Health Officer, Centene Corporation; Cheryl Pegus, MD, MPH, Partner, Morgan Health Ventures; Mario Schlosser, Co-founder & President of Technology, Oscar Health; Neil de Crescenzo, CEO, Optum Insight; Clive Fields, MD, Co-founder & Chief Medical Officer, VillageMD; Laura Kaiser, President & CEO, SSM Health; Bernd Montag, PhD, CEO, Siemens Healthineers; Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy and fo
Source: www.healthevolution.comCategories: Latest Headlines, Oncologists1Tweet-
Great write-up of the key themes at @HealthEvolution Summit this year, including from my talk with Joaquin Duato, Chairman & CEO, @JNJNews. Getting ready for Health Evolution Connect in a few weeks! https://t.co/o19KBHzsfX
-
-
Mashup Score: 1Opinion: Helpful assistant or job destroyer? How AI might change the future of work | CNN - 8 month(s) ago
To get a better sense of the effect AI might have on different industries across the labor market, we reached out to experts in medicine, law, art, retail, film, tech, education and agriculture.
Source: www.cnn.comCategories: Hem/Oncs, Latest HeadlinesTweet-
My colleague @erichhuang insightfully captured the impact #AI can have on medicine in this @CNN op-ed. AI will help reduce the administrative burden on clinical staff, but as Erich writes, it cannot replace trained doctors and nurses. https://t.co/AfGjjZkAa4
-
-
Mashup Score: 2
Read chapter Front Matter: Advances in biomedical science, data science, engineering, and technology are leading to high-pace innovation with potential to…
Source: nap.nationalacademies.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Today @theNAMedicine and @NASEM_Health released a new report exploring what's needed to advance equitable innovation in health & medicine, including across clinical evidence generation. Proud to be part of this effort along with my esteemed co-authors. https://t.co/LiaOeJY7Y0 https://t.co/pCg2DqRIo0
-
-
Mashup Score: 2Automating for Inclusivity: Healthcare’s Greatest Opportunity - 9 month(s) ago
Big data talks a big game. From drug makers to providers and payers – everyone benefits when clinical data is used in a way that makes care and treatment more inclusive. AI has already been used successfully to ensure clinical trials are more diverse, including a COVID-19 vaccine candidate, and the industry has a massive opportunity to continue leveraging AI to automate inclusivity throughout the healthcare journey starting at the beginning. Hear how industry leaders are addressing bias in AI, using automation and data to improve outcomes and why this is our biggest opportunity in healthcare.
Source: panelpicker.sxsw.comCategories: Hem/Oncs, Latest HeadlinesTweet-
It’s an honor to be considered for two panels at #SXSW 2024. Both discussions will speak to how #AI is being used to improve health for all. Please vote, and I hope to see you there! Automating for inclusivity: https://t.co/sk5Wkgowpv AI in Healthcare: https://t.co/jRr7ivn6W2
-
-
Mashup Score: 6Cosmetics companies take a page from precision medicine's playbook - 9 month(s) ago
Cosmetics giant L’Oreal is teaming up with Google spinout Verily to conduct a 10,000-person study.
Source: www.axios.comCategories: Latest Headlines, Oncologists1Tweet-
Always a pleasure to speak with @TreedinDC! Here she dives into our collaboration with @LOrealParisUSA as we work to build the world's largest and most diverse longitudinal skin study: https://t.co/pOZtPUhS0a https://t.co/OxFdNYWJu0
-
-
Mashup Score: 7
We are an Alphabet company focused on applying AI & data science to accelerate evidence generation and enable more precise interventions.
Source: verily.comCategories: Hem/Oncs, Latest HeadlinesTweet-
In this new blog post, I speak to our journey and progress at @Verily, as we work to bridge research and care and generate the evidence needed for #precisionhealth. Huge shoutout to our incredible teams progressing this work every day! https://t.co/W735tiUas4
-
This new scorecard will help guide innovation post COVID-19. So pleased to have shared my perspective for the report. Read it here: https://t.co/iYx7vkwDEU https://t.co/vkAFDVjUMP